129 related articles for article (PubMed ID: 8266228)
21. Immunization: a key to primary health care.
Program for Appropriate Technology in Health PATH
Health Technol Dir; 1983 Jan; 3(1):1-6. PubMed ID: 12268557
[TBL] [Abstract][Full Text] [Related]
22. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
23. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
24. Relationship between vaccine vial monitors and cold chain infrastructure in a rural district of India.
Samant Y; Lanjewar H; Parker L; Block D; Stein B; Tomar G
Rural Remote Health; 2007; 7(1):617. PubMed ID: 17288508
[TBL] [Abstract][Full Text] [Related]
25. Stability of yellow fever vaccine.
Monath TP
Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of the cold chain during the national antipoliomyelitis vaccination days. Mexico, 1987-1988].
Camacho-Amor ML; Morales-Romo A; Calvo A; Díaz-Ortega JL; Valdespino-Gómez JL; González-Velázquez MS; Islas-Romero R; Salcedo-Alvarez RA; Javier-Ponce de León V
Salud Publica Mex; 1990; 32(1):43-51. PubMed ID: 2330513
[TBL] [Abstract][Full Text] [Related]
27. Live viral vaccine potency: an index for assessing the cold chain system.
Adu FD; Adedeji AA; Esan JS; Odusanya OG
Public Health; 1996 Nov; 110(6):325-30. PubMed ID: 8979747
[TBL] [Abstract][Full Text] [Related]
28. Vaccines: quality issues.
Sokhey J; Sarkar S
J Indian Med Assoc; 2000 Jan; 98(1):22-3. PubMed ID: 11016141
[TBL] [Abstract][Full Text] [Related]
29. Guidelines for maintaining and managing the vaccine cold chain.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(42):1023-5. PubMed ID: 14574279
[TBL] [Abstract][Full Text] [Related]
30. WHO recommendation on potential use of new poliomyelitis vaccines.
Ghendon Y
Dev Biol Stand; 1993; 78():133-7; discussion 138-9. PubMed ID: 8388823
[TBL] [Abstract][Full Text] [Related]
31. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
32. Development of measles vaccines in Japan.
Ueda S
Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
[TBL] [Abstract][Full Text] [Related]
33. Power cuts and EPI vaccine storage.
Senanayake MP; Perera AS; De Silva TU
Ceylon Med J; 1997 Jun; 42(2):69-71. PubMed ID: 9257464
[TBL] [Abstract][Full Text] [Related]
34. [Analysis and evaluation on quality of live attenuated measles vaccine from market surveillance sampling].
Fang HH; Wang XX; Yi M
Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):511-5. PubMed ID: 20518326
[TBL] [Abstract][Full Text] [Related]
35. Recommended childhood immunization schedule--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(2):35-40. PubMed ID: 9011782
[TBL] [Abstract][Full Text] [Related]
36. Laboratory acute flaccid paralysis surveillance in Malaysia: a decade of commitment to the WHO global polio eradication initiative.
Saraswathy TS; Khairullah NS; Sinniah M; Fauziah MK; Apandi MY; Shamsuddin M
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):421-4. PubMed ID: 15691149
[TBL] [Abstract][Full Text] [Related]
37. Vaccines produced in diploid cell lines.
Ikić D
Natl Cancer Inst Monogr; 1968 Dec; 29():485-93. PubMed ID: 4976866
[No Abstract] [Full Text] [Related]
38. Use of animals in the development and control of viral vaccines.
Minor PD
Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
[TBL] [Abstract][Full Text] [Related]
40. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
